Clinical Trial Update: Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that luspatercept is being studied in Phase 1/2 for treating anemia after allogeneic hematopoietic stem cell transplantatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Acute Leukemia | Phase 1, Phase 2 | Status: RECRUITING